• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Role of T cell subsets in lethal graft-versus-host disease (GVHD) directed to class I versus class II H-2 differences. I. L3T4+ cells can either augment or retard GVHD elicited by Lyt-2+ cells in class I different hosts.T细胞亚群在针对I类与II类H-2差异的致死性移植物抗宿主病(GVHD)中的作用。I. 在I类不同宿主中,L3T4 +细胞可增强或延缓由Lyt-2 +细胞引发的GVHD。
J Exp Med. 1988 Feb 1;167(2):556-69. doi: 10.1084/jem.167.2.556.
2
Role of T cell subsets in lethal graft-versus-host disease (GVHD) directed to class I versus class II H-2 differences. II. Protective effects of L3T4+ cells in anti-class II GVHD.T细胞亚群在针对I类与II类H-2差异的致死性移植物抗宿主病(GVHD)中的作用。II. L3T4+细胞在抗II类GVHD中的保护作用。
J Immunol. 1990 Apr 15;144(8):2946-54.
3
Surface markers of T cells causing lethal graft-vs-host disease to class I vs class II H-2 differences.导致致死性移植物抗宿主病的T细胞表面标志物与I类和II类H-2差异。
J Immunol. 1985 Nov;135(5):3004-10.
4
Clonal analysis of murine graft-vs-host disease. I. Phenotypic and functional analysis of T lymphocyte clones.小鼠移植物抗宿主病的克隆分析。I. T淋巴细胞克隆的表型和功能分析。
J Immunol. 1986 May 15;136(10):3543-8.
5
Role of L3T4+ and Lyt-2+ donor cells in graft-versus-host immune deficiency induced across a class I, class II, or whole H-2 difference.L3T4+和Lyt-2+供体细胞在跨越I类、II类或整个H-2差异诱导的移植物抗宿主免疫缺陷中的作用。
J Immunol. 1988 Apr 15;140(8):2600-8.
6
Lethal graft-vs-host disease across major histocompatibility barriers: requirement for leucyl-leucine methyl ester sensitive cytotoxic T cells.主要组织相容性屏障间的致死性移植物抗宿主病:对亮氨酰 - 亮氨酸甲酯敏感的细胞毒性T细胞的需求。
J Immunol. 1987 Jan 1;138(1):51-7.
7
L3T4-positive T cells participate in the induction of graft-vs-host disease in response to minor histocompatibility antigens.L3T4阳性T细胞在对次要组织相容性抗原的应答中参与移植物抗宿主病的诱导。
J Immunol. 1987 Oct 15;139(8):2511-5.
8
Role of cytotoxic T lymphocytes in the prevention of lupus-like disease occurring in a murine model of graft-vs-host disease.细胞毒性T淋巴细胞在预防移植物抗宿主病小鼠模型中发生的狼疮样疾病中的作用。
J Immunol. 1987 Sep 15;139(6):1840-9.
9
Properties of purified T cell subsets. I. In vitro responses to class I vs. class II H-2 alloantigens.纯化T细胞亚群的特性。I. 对I类与II类H-2同种异体抗原的体外反应。
J Exp Med. 1985 Dec 1;162(6):2068-88. doi: 10.1084/jem.162.6.2068.
10
Relationship among function, phenotype, and specificity in primary allospecific T cell populations: identification of phenotypically identical but functionally distinct primary T cell subsets that differ in their recognition of MHC class I and class II allodeterminants.原发性同种特异性T细胞群体中功能、表型和特异性之间的关系:鉴定表型相同但功能不同的原发性T细胞亚群,这些亚群在对MHC I类和II类同种异体决定簇的识别上存在差异。
J Immunol. 1987 Jan 1;138(1):10-7.

引用本文的文献

1
Protocol for X-ray irradiation of C57BL/6J recipient mice followed by the transplantation of mTomato-expressing bone marrow cells.C57BL/6J受体小鼠X射线照射及表达mTomato的骨髓细胞移植方案。
STAR Protoc. 2025 Mar 21;6(1):103504. doi: 10.1016/j.xpro.2024.103504. Epub 2024 Dec 18.
2
Insights into mechanisms of graft-versus-host disease through humanised mouse models.通过人源化小鼠模型深入了解移植物抗宿主病的机制。
Biosci Rep. 2022 Sep 30;42(9). doi: 10.1042/BSR20211986.
3
Purinergic Signalling in Allogeneic Haematopoietic Stem Cell Transplantation and Graft-versus-Host Disease.嘌呤能信号在异基因造血干细胞移植和移植物抗宿主病中的作用。
Int J Mol Sci. 2021 Aug 3;22(15):8343. doi: 10.3390/ijms22158343.
4
Mouse nidovirus LDV infection alleviates graft versus host disease and induces type I IFN-dependent inhibition of dendritic cells and allo-responsive T cells.鼠诺如病毒 LDV 感染可减轻移植物抗宿主病,并诱导 I 型干扰素依赖性抑制树突状细胞和同种反应性 T 细胞。
Immun Inflamm Dis. 2017 Jun;5(2):200-213. doi: 10.1002/iid3.157. Epub 2017 Apr 4.
5
Pathophysiology of GvHD and Other HSCT-Related Major Complications.移植物抗宿主病及其他造血干细胞移植相关主要并发症的病理生理学
Front Immunol. 2017 Mar 20;8:79. doi: 10.3389/fimmu.2017.00079. eCollection 2017.
6
Mouse models of graft-versus-host disease: advances and limitations.移植物抗宿主病的小鼠模型:进展与局限性。
Dis Model Mech. 2011 May;4(3):318-33. doi: 10.1242/dmm.006668.
7
Prevention of graft-versus-host disease by anti IL-7Ralpha antibody.抗IL-7Rα抗体预防移植物抗宿主病
Blood. 2007 Oct 15;110(8):2803-10. doi: 10.1182/blood-2006-11-055673. Epub 2007 Jun 26.
8
The pathophysiology of acute graft-versus-host disease.急性移植物抗宿主病的病理生理学
Int J Hematol. 2003 Oct;78(3):181-7. doi: 10.1007/BF02983793.
9
Regulatory role of CD4+ T cells during the development of contact hypersensitivity responses.CD4+ T细胞在接触性超敏反应发生过程中的调节作用。
Immunol Res. 2001;24(1):69-77. doi: 10.1385/IR:24:1:69.
10
IL-11 separates graft-versus-leukemia effects from graft-versus-host disease after bone marrow transplantation.白细胞介素-11可在骨髓移植后将移植物抗白血病效应与移植物抗宿主病区分开来。
J Clin Invest. 1999 Aug;104(3):317-25. doi: 10.1172/JCI7111.

本文引用的文献

1
Studies on mouse leukaemia. The role of the thymus in leukaemogenesis by cell-free leukaemic filtrates.小鼠白血病研究。胸腺在无细胞白血病滤液致白血病过程中的作用。
Br J Cancer. 1960 Mar;14(1):93-8. doi: 10.1038/bjc.1960.11.
2
Lethal murine graft-versus-host disease in the absence of detectable cytotoxic T lymphocytes.在无可检测到的细胞毒性T淋巴细胞的情况下发生的致死性小鼠移植物抗宿主病。
Transplantation. 1983 Sep;36(3):281-9. doi: 10.1097/00007890-198309000-00011.
3
Allogenic bone marrow transplantation: current status and future directions.同种异体骨髓移植:现状与未来方向。
Blood. 1983 Nov;62(5):941-64.
4
Allosuppressor- and allohelper-T cells in acute and chronic graft-vs.-host (GVH) disease. III. Different Lyt subsets of donor T cells induce different pathological syndromes.急性和慢性移植物抗宿主病(GVH)中的同种抑制性和同种辅助性T细胞。III. 供体T细胞的不同Lyt亚群诱导不同的病理综合征。
J Exp Med. 1983 Aug 1;158(2):546-58. doi: 10.1084/jem.158.2.546.
5
Allosuppressor and allohelper T cells in acute and chronic graft-vs.-host disease. II. F1 recipients carrying mutations at H-2K and/or I-A.急性和慢性移植物抗宿主病中的同种抑制性和同种辅助性T细胞。II. 在H-2K和/或I-A携带突变的F1受体。
J Exp Med. 1983 Feb 1;157(2):755-71. doi: 10.1084/jem.157.2.755.
6
Cellular immunology and the pathogenesis of graft versus host reactions.细胞免疫学与移植物抗宿主反应的发病机制。
Prog Allergy. 1971;15:78-187.
7
Surface markers of T cells causing lethal graft-vs-host disease to class I vs class II H-2 differences.导致致死性移植物抗宿主病的T细胞表面标志物与I类和II类H-2差异。
J Immunol. 1985 Nov;135(5):3004-10.
8
T-cell depletion of allogeneic bone marrow prevents acceleration of graft-versus-host disease induced by exogenous interleukin 2.异体骨髓的T细胞清除可防止外源性白细胞介素2诱导的移植物抗宿主病加速。
Cell Immunol. 1986 Dec;103(2):476-80. doi: 10.1016/0008-8749(86)90108-5.
9
Monoclonal antibodies for the prevention of graft-versus-host disease and marrow graft rejection. The depletion of T cell subsets in vitro and in vivo.用于预防移植物抗宿主病和骨髓移植排斥反应的单克隆抗体。T细胞亚群在体内外的清除。
Transplantation. 1986 Sep;42(3):239-47. doi: 10.1097/00007890-198609000-00003.
10
Properties of purified T cell subsets. II. In vivo responses to class I vs. class II H-2 differences.纯化T细胞亚群的特性。II. 对I类与II类H-2差异的体内反应。
J Exp Med. 1986 Apr 1;163(4):998-1011. doi: 10.1084/jem.163.4.998.

T细胞亚群在针对I类与II类H-2差异的致死性移植物抗宿主病(GVHD)中的作用。I. 在I类不同宿主中,L3T4 +细胞可增强或延缓由Lyt-2 +细胞引发的GVHD。

Role of T cell subsets in lethal graft-versus-host disease (GVHD) directed to class I versus class II H-2 differences. I. L3T4+ cells can either augment or retard GVHD elicited by Lyt-2+ cells in class I different hosts.

作者信息

Sprent J, Schaefer M, Gao E K, Korngold R

机构信息

Department of Immunology, Research Institute of Scripps Clinic, La Jolla, California 92037.

出版信息

J Exp Med. 1988 Feb 1;167(2):556-69. doi: 10.1084/jem.167.2.556.

DOI:10.1084/jem.167.2.556
PMID:2964497
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2188839/
Abstract

Detailed information was sought on the capacity of purified Lyt-2+ cells to mediate lethal graft-versus-host disease (GVHD) directed to class I H-2 differences. When B6 Lyt-2+ cells were transferred to irradiated class I-different (B6 x bm 1)F1 mice, three different patterns of lethal GVHD were observed. First, rapid death from hematopoietic failure occurred when Lyt-2+ cells were transferred together with host-type marrow cells; this form of GVHD probably reflected direct destruction of stem cells by Lyt-2+ cytotoxic cells. Second, a pattern of late-onset, chronic GVHD resulting in death only after 4-6 wk occurred when Lyt-2+ cells were supplemented with donor marrow. This syndrome developed in the apparent absence of L3T4+ cells and was observed with either high or low doses of Lyt-2+ cells and with either light or heavy irradiation of the host. Third, an acute form of GVHD resulted when Lyt-2+ cells plus donor marrow cells were supplemented with exogenous help, i.e., by adding small doses of donor L3T4+ cells or injecting the hosts with rIL-2. Although L3T4+ cells potentiated GVHD when injected in small doses, supplementing Lyt-2+ cells with large doses of L3T4+ cells paradoxically led to marked protection; symptoms of GVHD were mild and no deaths occurred.

摘要

我们研究了纯化的Lyt-2⁺细胞介导针对I类H-2差异的致死性移植物抗宿主病(GVHD)的能力。当将B6 Lyt-2⁺细胞转移至经照射的I类不同(B6×bm1)F1小鼠时,观察到三种不同模式的致死性GVHD。首先,当Lyt-2⁺细胞与宿主型骨髓细胞一起转移时,会因造血功能衰竭而迅速死亡;这种形式的GVHD可能反映了Lyt-2⁺细胞毒性细胞对干细胞的直接破坏。其次,当Lyt-2⁺细胞补充有供体骨髓时,会出现一种迟发性慢性GVHD模式,仅在4-6周后导致死亡。这种综合征在明显缺乏L3T4⁺细胞的情况下发生,并且在高剂量或低剂量的Lyt-2⁺细胞以及宿主接受轻度或重度照射时均观察到。第三,当Lyt-2⁺细胞加供体骨髓细胞补充外源性辅助,即添加小剂量供体L3T4⁺细胞或给宿主注射rIL-2时,会导致急性GVHD形式。尽管小剂量注射L3T4⁺细胞可增强GVHD,但用大剂量L3T4⁺细胞补充Lyt-2⁺细胞却反常地导致明显的保护作用;GVHD症状轻微且无死亡发生。